phase 2 vs triple agonist — genuinely asking which matters more
Long-ish post, sorry. tl;dr at the bottom. I have been tracking retatrutide against triglycerides for 31 weeks because I could not find anyone who had. The correlation is weaker than I expected, which is itself mildly interesting given how confidently people link the two in here. Caveats up front: one person, one…
Every time this gets posted it hits the front page and every time someone has to re-explain it.
Sceptical. If this were true we would see it reflected in the data and we do not.
[deleted]
triple agonism is glucagon, do not generalise
nobody should be giving this to anyone without extensive monitoring
Dose escalation on retatrutide is steeper and faster than on semaglutide. Do not assume the titration patterns transfer.
the 0.5mg arm is different from 0.25mg, results do not transfer